Skip to main content

Vireo Growth Inc.

VREOF
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001771706

No open-market purchases or sales by Vireo Growth Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding Vireo Growth Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of VREOF: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders21−1
Shares40.1K80.0K+39.9K (+99.6%)
Value$49.4K$75.0K+$25.6K (+51.8%)

New holders (0)

Institutions that held Vireo Growth Inc. at the end of Q3 2022 but not at the end of Q2 2022.

None.

Sold out (1)

Institutions that held Vireo Growth Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of VREOF in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Castleview Partners, LLC72$398